Background
copied from the UKCTOCS website:
"Large studies performed by our research team and other international teams during the last decade have developed and refined two methods of screening. One method uses ultrasound scanning, similar to the scanning used in pregnancy, to check for any enlargement or abnormality of the ovaries. Ultrasound is currently widely used for diagnosing ovarian cancer in women with symptoms. It has been shown that the ultrasound test can be abnormal in the early stage of many ovarian cancers. This trial will use a method of ultrasound scanning called "transvaginal scan" whereby a probe is inserted into the vagina to see the ovaries. This method of scanning gives a much clearer picture of the ovaries than a transabdominal scan, where the probe is placed on the abdomen. The second method involves a blood test to measure a substance called CA 125. Most women who develop ovarian cancer have high levels of the protein called CA125 in their blood. "
Origins of the URA System
The URA System was conceived to archive the ultrasound images being recorded as part of the trial. The system is introduced at the end of the workflow when the images arrive at Maple House.